“A clinical impact study of dermatologists’ use of the 23- or 35-gene expression profile tests to guide surgical excision and enhance management plan confidence” (2022) SKIN The Journal of Cutaneous Medicine, 6(6), p. s99. doi:10.25251/skin.6.supp.99.